Items tagged with Drug-resistant TB
The remarkable story of hope: how attitudes to drug-resistant TB changed (post)
The informal settlement of Khayelitsha in Cape Town is the latest site of a multi country trial that aims to transform the treatment for drug-resistant tuberculosis (DR-TB).
Real-time, web-based tool to revolutionise drug-resistant TB treatment (post)
Melbourne researchers have designed a computer-generated model that will allow clinicians to tailor effective therapies for individual patients with multidrug-resistant tuberculosis (MDRTB), and as a result, reduce drug resistance globally.
Confronting TB resistance (post)
Tuberculosis, caused by Mycobacterium tuberculosis, is a highly infectious lung disease in humans.Unfortunately, resistance to anti-tubercular medicines such as fourth-generation fluoroquinolones is on the rise. In most cases, fluoroquinolone resistance is caused by mutations in a bacterial enzyme called gyrase.
South Africa: the country where political leadership serves the people (post)
In an unprecedented and historic move, South African Department of Health decided to recommend including bedaquiline as the standard treatment for patients with drug-resistant TB (DR-TB). The country also released data showing that treatment regimens including bedaquiline reduced mortality three-fold compared with those without bedaquiline.
Kanchan Mukherjee: Bedaquiline for multidrug-resistant TB in India — at what cost? (post)
In a blog post in The BMJ Opinion, Kanchan Mukherjee, a medical doctor and professor at the Tata Institute of Social Sciences in Mumbai, discusses the potential benefits and challenges of a wider government rollout of bedaquiline to treat multidrug-resistant TB in India.
Webinar: Challenges with MDR-TB clinical trial implementation (post)
TREAT TB will host a webinar on 10 July 2018 on challenges with multidrug-resistant TB (MDR-TB) clinical trial implementation - sponsor and site perspectives.
From decades to days: 3D modelling tuberculosis (post)
3D modelling of the mutations in TB means doctors around the world could soon tailor individual treatments for the disease in a matter of days, rather than years.
The 'hell' of fighting drug-resistant TB causes some to abandon treatment (post)
ESHOWE, South Africa — Canadian Press reporters travelled to South Africa and India to investigate the growing epidemic of drug resistance, which experts describe as the single greatest threat to human health on the planet. This is the fifth story of a six-part series exploring how the unfettered use of antibiotics pushes humanity closer to a post-antibiotic era in which common infections may be impossible to treat. The R. James Travers Foreign Corresponding Fellowship helped fund the project.
South African TB study finds lower death rate with bedaquiline (post)
In a study that could have an impact on the treatment of drug-resistant tuberculosis (TB), a team of South African researchers report that the novel TB drug bedaquiline was associated with a significant reduction in mortality for patients with multidrug-resistant (MDR), rifampicin-resistant, and extensively drug-resistant (XDR) strains of the infection.
Webinar: Implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB (post)
Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and DR-TB STAT will host a webinar on 1 August 2018 at 10 am New York / 4pm South Africa / 5pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB.
Page 51 of 117 · Total posts: 0
←First 50 51 52 Last→